Transfection of HepG2 cells with infectious hepatitis C virus genome (original) (raw)

. 1997 Aug;151(2):363–373.

Abstract

Hepatitis C virus (HCV) represents one of the major causes of acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) around the world. Our knowledge of the life cycle of HCV, however, is limited. Current studies are hampered by the lack of a reproducible, high-level in vitro replication system of HCV. We sought to establish HCV replication in HepG2 cells by gene transfer of in vitro transcribed HCV RNA. In preliminary experiments, diethylaminoethyl-dextran led to more efficient gene transfer than cationic liposomes (lipofectin, lipofectamine, and DOTAP). Therefore, in subsequent experiments, HepG2 cells were transfected with full-length (9.6-kb) and near-full-length (9.4-kb) HCV RNA using diethylaminoethyl-dextran. Transfection with subgenomic HCV RNA and mock transfection were used as controls. Positive- and negative-strand HCV RNA sequences were detected by reverse transcription polymerase chain reaction (KT-PCR) for 60 days in the infectious HCV RNA transfected HepG2 cells. The presence of negative-strand HCV RNA, presumably representing replicative intermediates, was confirmed by ribonuclease protection assay. The intracellular levels of HCV RNA were measured by quantitative competitive RT-PCR from 10 to 50 days after transfection and were stable over this time period at moderately high levels (10(8) to 10(10) genomes per mg of total RNA). Expression of viral core and nonstructural proteins was detected in the cytoplasm of transfected cells by immunostaining. Virus-like particles measuring 50 to 60 nm in diameter were found by electron microscopy in cytoplasmic vesicles and conditioned media of the cells transfected with infectious HCV RNA but not in cells transfected with truncated HCV RNA. Culture supernatants of infectious HCV RNA transfected HepG2 cells were infectious for Daudi cells for three passages tested. The truncated HCV RNA lacking NS5 and 3' untranslated region (3' UTR) of HCV was replication incompetent. This is the first demonstration of HCV particles in HepG2 cells after transfection with infectious HCV RNA. We conclude that we have established a reproducible HCV replication system in HepG2 cells that can be used to study the life cycle of HCV and to test anti-HCV agents.

363

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behrens S. E., Tomei L., De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 1996 Jan 2;15(1):12–22. [PMC free article] [PubMed] [Google Scholar]
  2. Bergmann M., García-Sastre A., Palese P. Transfection-mediated recombination of influenza A virus. J Virol. 1992 Dec;66(12):7576–7580. doi: 10.1128/jvi.66.12.7576-7580.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertolini L., Iacovacci S., Ponzetto A., Gorini G., Battaglia M., Carloni G. The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Res Virol. 1993 Jul-Aug;144(4):281–285. doi: 10.1016/s0923-2516(06)80041-5. [DOI] [PubMed] [Google Scholar]
  4. Chapman N. M., Tu Z., Tracy S., Gauntt C. J. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol. 1994;135(1-2):115–130. doi: 10.1007/BF01309769. [DOI] [PubMed] [Google Scholar]
  5. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  6. Cohen J. I., Ticehurst J. R., Feinstone S. M., Rosenblum B., Purcell R. H. Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol. 1987 Oct;61(10):3035–3039. doi: 10.1128/jvi.61.10.3035-3039.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fisher A. G., Collalti E., Ratner L., Gallo R. C., Wong-Staal F. A molecular clone of HTLV-III with biological activity. Nature. 1985 Jul 18;316(6025):262–265. doi: 10.1038/316262a0. [DOI] [PubMed] [Google Scholar]
  8. Fong T. L., Shindo M., Feinstone S. M., Hoofnagle J. H., Di Bisceglie A. M. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest. 1991 Sep;88(3):1058–1060. doi: 10.1172/JCI115368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gerber M. A., Shieh Y. S., Shim K. S., Thung S. N., Demetris A. J., Schwartz M., Akyol G., Dash S. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am J Pathol. 1992 Dec;141(6):1271–1277. [PMC free article] [PubMed] [Google Scholar]
  10. Hagiwara H., Hayashi N., Mita E., Naito M., Kasahara A., Fusamoto H., Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology. 1993 Apr;17(4):545–550. doi: 10.1002/hep.1840170404. [DOI] [PubMed] [Google Scholar]
  11. Hahn C. S., Hahn Y. S., Braciale T. J., Rice C. M. Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2679–2683. doi: 10.1073/pnas.89.7.2679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harada T., Kim D. W., Sagawa K., Suzuki T., Takahashi K., Saito I., Matsuura Y., Miyamura T. Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral cDNA. J Gen Virol. 1995 May;76(Pt 5):1215–1221. doi: 10.1099/0022-1317-76-5-1215. [DOI] [PubMed] [Google Scholar]
  13. Haruna Y., Hayashi N., Kamada T., Hytiroglou P., Thung S. N., Gerber M. A. Expression of hepatitis C virus in hepatocellular carcinoma. Cancer. 1994 May 1;73(9):2253–2258. doi: 10.1002/1097-0142(19940501)73:9<2253::aid-cncr2820730904>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  14. Houghton M., Weiner A., Han J., Kuo G., Choo Q. L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991 Aug;14(2):381–388. [PubMed] [Google Scholar]
  15. Kaito M., Watanabe S., Tsukiyama-Kohara K., Yamaguchi K., Kobayashi Y., Konishi M., Yokoi M., Ishida S., Suzuki S., Kohara M. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol. 1994 Jul;75(Pt 7):1755–1760. doi: 10.1099/0022-1317-75-7-1755. [DOI] [PubMed] [Google Scholar]
  16. Kato N., Nakazawa T., Mizutani T., Shimotohno K. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem Biophys Res Commun. 1995 Jan 26;206(3):863–869. doi: 10.1006/bbrc.1995.1123. [DOI] [PubMed] [Google Scholar]
  17. Kolykhalov A. A., Feinstone S. M., Rice C. M. Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol. 1996 Jun;70(6):3363–3371. doi: 10.1128/jvi.70.6.3363-3371.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lai C. J., Zhao B. T., Hori H., Bray M. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5139–5143. doi: 10.1073/pnas.88.12.5139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lanford R. E., Sureau C., Jacob J. R., White R., Fuerst T. R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 1994 Aug 1;202(2):606–614. doi: 10.1006/viro.1994.1381. [DOI] [PubMed] [Google Scholar]
  20. McGuinness P. H., Bishop G. A., Painter D. M., Chan R., McCaughan G. W. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology. 1996 Apr;23(4):676–687. doi: 10.1002/hep.510230404. [DOI] [PubMed] [Google Scholar]
  21. Mellits K. H., Pe'ery T., Manche L., Robertson H. D., Mathews M. B. Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector. Nucleic Acids Res. 1990 Sep 25;18(18):5401–5406. doi: 10.1093/nar/18.18.5401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Men R., Bray M., Clark D., Chanock R. M., Lai C. J. Dengue type 4 virus mutants containing deletions in the 3' noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys. J Virol. 1996 Jun;70(6):3930–3937. doi: 10.1128/jvi.70.6.3930-3937.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mizuno M., Yamada G., Tanaka T., Shimotohno K., Takatani M., Tsuji T. Virion-like structures in HeLa G cells transfected with the full-length sequence of the hepatitis C virus genome. Gastroenterology. 1995 Dec;109(6):1933–1940. doi: 10.1016/0016-5085(95)90761-0. [DOI] [PubMed] [Google Scholar]
  24. Racaniello V. R., Baltimore D. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science. 1981 Nov 20;214(4523):916–919. doi: 10.1126/science.6272391. [DOI] [PubMed] [Google Scholar]
  25. Selby M. J., Choo Q. L., Berger K., Kuo G., Glazer E., Eckart M., Lee C., Chien D., Kuo C., Houghton M. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol. 1993 Jun;74(Pt 6):1103–1113. doi: 10.1099/0022-1317-74-6-1103. [DOI] [PubMed] [Google Scholar]
  26. Shimizu Y. K., Feinstone S. M., Kohara M., Purcell R. H., Yoshikura H. Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology. 1996 Feb;23(2):205–209. doi: 10.1002/hep.510230202. [DOI] [PubMed] [Google Scholar]
  27. Shimizu Y. K., Iwamoto A., Hijikata M., Purcell R. H., Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5477–5481. doi: 10.1073/pnas.89.12.5477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shimizu Y. K., Purcell R. H., Yoshikura H. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6037–6041. doi: 10.1073/pnas.90.13.6037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sumiyoshi H., Hoke C. H., Trent D. W. Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol. 1992 Sep;66(9):5425–5431. doi: 10.1128/jvi.66.9.5425-5431.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sussman D. J., Milman G. Short-term, high-efficiency expression of transfected DNA. Mol Cell Biol. 1984 Aug;4(8):1641–1643. doi: 10.1128/mcb.4.8.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991 Mar;65(3):1105–1113. doi: 10.1128/jvi.65.3.1105-1113.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Takehara T., Hayashi N., Miyamoto Y., Yamamoto M., Mita E., Fusamoto H., Kamada T. Expression of the hepatitis C virus genome in rat liver after cationic liposome-mediated in vivo gene transfer. Hepatology. 1995 Mar;21(3):746–751. [PubMed] [Google Scholar]
  33. Tanaka T., Kato N., Cho M. J., Shimotohno K. A novel sequence found at the 3' terminus of hepatitis C virus genome. Biochem Biophys Res Commun. 1995 Oct 13;215(2):744–749. doi: 10.1006/bbrc.1995.2526. [DOI] [PubMed] [Google Scholar]
  34. Tanaka T., Kato N., Cho M. J., Sugiyama K., Shimotohno K. Structure of the 3' terminus of the hepatitis C virus genome. J Virol. 1996 May;70(5):3307–3312. doi: 10.1128/jvi.70.5.3307-3312.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wallner G., Mandl C. W., Kunz C., Heinz F. X. The flavivirus 3'-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus. Virology. 1995 Oct 20;213(1):169–178. doi: 10.1006/viro.1995.1557. [DOI] [PubMed] [Google Scholar]
  36. Weiss B. G., Schlesinger S. Recombination between Sindbis virus RNAs. J Virol. 1991 Aug;65(8):4017–4025. doi: 10.1128/jvi.65.8.4017-4025.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yamada N., Tanihara K., Takada A., Yorihuzi T., Tsutsumi M., Shimomura H., Tsuji T., Date T. Genetic organization and diversity of the 3' noncoding region of the hepatitis C virus genome. Virology. 1996 Sep 1;223(1):255–261. doi: 10.1006/viro.1996.0476. [DOI] [PubMed] [Google Scholar]
  38. Yoo B. J., Selby M. J., Choe J., Suh B. S., Choi S. H., Joh J. S., Nuovo G. J., Lee H. S., Houghton M., Han J. H. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. J Virol. 1995 Jan;69(1):32–38. doi: 10.1128/jvi.69.1.32-38.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van der Werf S., Bradley J., Wimmer E., Studier F. W., Dunn J. J. Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2330–2334. doi: 10.1073/pnas.83.8.2330. [DOI] [PMC free article] [PubMed] [Google Scholar]